Top Markets
Coin of the day
Liminal BioSciences Inc. Liminal BioSciences Inc.

Liminal BioSciences Inc.

LMNL
Classificação em ações #38948
Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm,... Liminal BioSciences Inc. operates as a clinical-stage biopharmaceutical firm, primarily engaged in creating innovative small molecule drug therapies. The company concentrates on addressing inflammatory, fibrotic, and metabolic diseases, with its operations spanning Canada and the United Kingdom. Its flagship drug candidate, fezagepras (identified as PBI-4050), has successfully advanced through Phase I clinical trials. This agent, along with its related derivatives, is undergoing investigation for potential application in treating idiopathic fibrosis affecting the lungs, liver, heart, or skin, as well as various respiratory conditions. Furthermore, Liminal is advancing antagonist programs, including G-protein coupled receptor 84 (GPR84) and Oxo-eicosanoid receptor 1 (OXER1), both of which are currently in preclinical development. Formerly known as Prometic Life Sciences Inc., the company adopted the name Liminal BioSciences Inc. in October 2019. Established in 1994, its corporate headquarters are located in Laval, Canada.
Preço da ação
$8.50
Última sincronização: 2023-09-26
Valor de mercado
$719.10K
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
CA
Negociar Liminal BioSciences Inc. (LMNL)

Categoria

Histórico de preços das ações de Liminal BioSciences Inc. (LMNL)
Preço de fecho mais alto: $8.45 em 2023-09-01

Preço de fecho mais baixo: $1.69K em 2009-12-01
Histórico de preços das ações da Liminal BioSciences Inc. de 2009 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2023 112.62%
2022 -61.46%
2021 -76.57%
2020 -35.75%
2019 -97.45%
2018 -73.89%
2017 -28.49%
2016 -38.09%
2015 36.88%
2014 102.93%
2013 334.33%
2012 40.83%
2011 23.59%
2010 -34.41%
2009 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$507.69 30.08%
US
$848.55 30.06%
NL
$731.69 7.13%
CH
$1.07K -6.40%
KR
$251.82 11.25%
BE